Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemosensitivity Test for Adjuvant S-1 in Gastric Cancer
NCT00287755Phase 2Completed
- Sponsor
- Japan Clinical Cancer Research Organization
- Start
- Mar 2006
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur in gastric cancer (GC), sponsored by Japan Clinical Cancer Research Organization. Primary endpoint: Disease-Free Survival at 3 years. Started Mar 2006; status: completed.
02
Drugs
tegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00287755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00287755.